Keywords
Mental Health
Omega-3 Fatty Acids
Neurodegenerative Diseases
Depression
Brain Aging
Categories
How to Cite
Abstract
Introduction: The objective of this systematic review is to analyze the available scientific evidence on the effects of omega-3 fatty acids on mental and neurological health. The objective of this systematic review is to analyze the available scientific evidence on the effects of omega-3 fatty acids on mental and neurological health. Methods: This systematic review is based on a rigorous search, analysis and synthesis of scientific literature that examines how omega-3 intake -especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)- affects clinical and functional outcomes in various mental and neurodegenerative disorders. Results: The review was carried out following the methodological guidelines proposed by the PRISMA statement, which ensured a transparent, exhaustive and carefully structured process at each stage. At the beginning, a total of 2,745 records were identified from four scientific databases recognized for their specialization in health and nutrition: PubMed, Web of Science, ScienceDirect and Google Scholar. Conclusion: The studies analyzed reveal that the therapeutic effects of omega-3 fatty acids on mental and cognitive health are highly contextual and heterogeneous, depending on factors such as age, clinical diagnosis, baseline state of the nervous system, type of intervention (dietary vs. supplementation) and the presence of inflammatory or antioxidant biomarkers.
References
World Health Organization. Mental health [Internet]. 2022 [citado 2025 Ago 24]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response
Naureen Z, Dhuli K, Medori MC, et al. Suplementos dietéticos en enfermedades neurológicas y envejecimiento cerebral. J Prev Med Hyg. 2022;63(2 Supl 3):E174–E188.
Debbabi M, Zarrouk A, Bezine M, et al. Comparison of the effects of major fatty acids present in the Mediterranean diet on neurotoxicity. Chem Phys Lipids. 2017;207:151–70.
Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):407–12.
Parletta N, Zarnowiecki D, Cho J, et al. A Mediterranean-style dietary intervention supplemented with fish oil improves mental health in people with depression. Nutr Neurosci. 2019;22(7):474–87.
Jacka FN, O'Neil A, Opie R, et al. A randomised controlled trial of dietary improvement for adults with major depression (SMILES trial). BMC Med. 2017;15:23.
Caballer García J, Torío Ojea E, Jiménez Treviño L, Sánchez Fernández S. Ácidos grasos omega-3 y depresión: una revisión sistemática. Psiquiatr Biol. 2017;24(1):10–17.
Appleton KM, Voyias PD, Sallis HM, et al. Omega-3 fatty acids for depression in adults. Cochrane Database Syst Rev. 2021;CD004692.
García-Toro M, Vicens-Pons E, Gili M, et al. Obesity, metabolic syndrome and Mediterranean diet: Impact on depression outcome. J Affect Disord. 2016;194:105–8.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Critical Appraisal Skills Programme (CASP). CASP checklists: Making sense of evidence [Internet]. Oxford: CASP UK; 2018 [cited 2025 Aug 21]. Available from: https://casp-uk.net/casp-tools-checklists/
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.
Amminger, G. P., Rice, S., Davey, C. G., Quinn, A. L., Hermens, D. F., Zmicerevska, N., Nichles, A., Hickie, I., Incerti, L., Weller, A., Joseph, S., Hilton, Z., Pugh, C., Rayner, M., Reid, N., Ratheesh, A., Yung, A. R., Yuen, H. P., Mackinnon, A., Hetrick, S., … Lin, A. (2024). The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. Biological psychiatry, 95(5), 426–433. https://doi.org/10.1016/j.biopsych.2023.06.015
Kolodziej, Piotr Lech Czarny, Sylwia Ziolkowska, Katarzyna Bialek, Janusz Szemraj, Piotr Galecki, Kuan-Pin Su, Tomasz Sliwinski, How fish consumption prevents the development of Major Depressive Disorder? A comprehensive review of the interplay between n-3 PUFAs, LTP and BDNF, Progress in Lipid Research, Volume 92, 2023,. https://www.sciencedirect.com/science/article/pii/S0163782723000449
Suh, S.W., Lim, E., Burm, SY. et al. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose–response meta-analysis. BMC Med 22, 109 (2024). https://doi.org/10.1186/s12916-024-03296-0
Ciappolino, V., DelVecchio, G., Prunas, C., Andreella, A., Finos, L., Caletti, E., Siri, F., Mazzocchi, A., Botturi, A., Turolo, S., Agostoni, C., & Brambilla, P. (2020). The Effect of DHA Supplementation on Cognition in Patients with Bipolar Disorder: An Exploratory Randomized Control Trial. Nutrients, 12(3), 708. https://doi.org/10.3390/nu12030708
Saunders, E. F. H., Mukherjee, D., Myers, T., Wasserman, E., Hameed, A., Bassappa Krishnamurthy, V., MacIntosh, B., Domenichiello, A., Ramsden, C. E., & Wang, M. (2022). Adjunctive dietary intervention for bipolar disorder: a randomized, controlled, parallel-group, modified double-blinded trial of a high n-3 plus low n-6 diet. Bipolar disorders, 24(2), 171–184. https://doi.org/10.1111/bdi.13112
Berger, M., Seemüller, F., Voggt, A., Obermeier, M., Kirchberg, F., Löw, A., Riedel, M., von Schacky, C., & Severus, E. (2022). Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the "BIPO-3" trial. International journal of bipolar disorders, 10(1), 9. https://doi.org/10.1186/s40345-022-00253-9
Eslahi, Hadi et al. “The effects of omega 3 fatty acids on the serum concentrations of pro inflammatory cytokines anddepression status in patients with bipolar disorder: A randomized double-blind controlled clinical trial.” Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 28 36. 21 Apr. 2023, doi:10.4103/jrms.jrms_342_22
Gholipour D, Shahraki M, Saravani M, Payandeh A, Eslahi H. The Effect of Omega-3 Supplementation on Serum Levels of Antioxidant Status in Patients With Bipolar Disease: A Randomized Double-blind Controlled Clinical Trial. BCN 2024; 15 (1) :109-116URL: http://bcn.iums.ac.ir/article-1-2490-en.html
McNamara, R.K.; Strawn, J.R.; Tallman, M.J.; Welge, J.A.; Patino, L.R.; Blom, T.J.; DelBello, M.P. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial. J. Child. Adolesc. Psychopharmacol. 2020, 30, 293–305
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 María Castro Penalonga, Lucía García-Bugallo, Cayetana Pena Vidal